MBCT for Depression
Role
MBCT is one of the most robustly evidence-based treatments available for a specific high-value target — reducing depression relapse risk by approximately 43% compared to treatment as usual for people with three or more previous episodes, and endorsed by NICE in the UK as a recommended treatment for recurrent depression. Its specific mechanism (building metacognitive awareness of depressive thought patterns rather than challenging their content) makes it particularly appropriate for the high-relapse population of recurrent depression, where the familiarity with the cognitive territory of depression allows pattern recognition to be the primary protective mechanism. Yet most people with recurrent depression have never been offered MBCT despite its evidence base and the devastating cumulative impact of repeated depressive episodes on their lives.